CVS Health / Aetna
What CVS Health / Aetna is up to now
New 08-16: no further movement — an explicit-zero Sunday for the mental-health lens (trade press doesn't publish weekends). One housekeeping note, not a CVS-side development: the `cvs-health` slug used in this lens's Aetna/Alma annotations had no formal watchlist entry, an orphan regularised today as "CVS Health / Aetna." New 08-15: the one open thread item from last week's Q2 print resolved this week — Aetna's reimbursement cuts to Alma-contracted behavioral-health therapists took effect 08-15 as scheduled, after a partial July rollback that dropped the two most aggressive original proposals (collapsing the 90837/90834 codes into one rate, flattening pay across license levels). What actually landed is real and state-specific: New York therapists lose 10.6% on a 60-minute session and 9.7% on intake, New Jersey loses 15.2%/16.8% on the same codes, 30-minute sessions untouched everywhere. Neither Aetna nor Alma issued a formal announcement — confirmed instead via a practice-management blog's published rate tables. Otherwise the 08-05 Q2 standing picture holds: FY26 guidance raised (adj. EPS $7.90-8.10, revenue >=$414B), Aetna operating income up >$2B YoY behind the 2nd-gen "Aetna Claims Assist Manager" tool, 1M pharmacist hours redirected to clinical care, stock still soft on the 2027 EPS floor.
as of 2026-08-16
Payer-PBM-pharmacy (+Aetna/Caremark); debt-laden and constrained.
The metrics
- Posture med
- retrenching 2 src →
- Capital · available high
- ~$9.5B cash + ~$2.3B short-term inv (~$34.7B total investments/float) against ~$78-80B total debt — the most leveraged payer here 1 src →
- Capital · operating high
- ~$402B FY25 revenue (~$408B TTM); operating cash flow ~$10.6B FY25 / ~$10.3B TTM 1 src →
- Capital · deployed high
- ~$2.8B capex + ~$0.4B small acquisitions FY25; buybacks essentially halted (~$158M) 1 src →
- Capital · in high
- inflows — ~$402B FY25 revenue: Aetna premiums + Caremark PBM + CVS Pharmacy retail 1 src →
- Capital · out high
- outflows — medical + pharmacy cost of goods dominate; then ~$3.4B dividends, ~$0.4B M&A, minimal (~$0.16B) buybacks, plus debt service on ~$78-80B 1 src →
- Optionality high
- constrained — MLR caps the Aetna insurance core AND ~$78-80B debt + a near-frozen buyback (cash to deleverage) leaves little dry powder; the freest lever is retail/PBM cost-cutting, not … 1 src →
- Gravity med
- GROSS ~$402B/yr routed — Caremark PBM 75M+ members, ~9,100-9,600 pharmacies (~1/5 of US scripts), Aetna medical members; a payer-PBM-pharmacy triple choke-point. 2 src →
Projects & threads
Full item history for CVS Health / Aetna →